Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Shah MH et al. - Bcl-2 antisense therapy (G3139) was well tolerated among patients with advanced MCC. Although probable antitumor activity was documented in 1 patient, no objective responses per Response Evaluation Criteria in Solid Tumors criteria were observed.


Today in Dermatologic Oncology...keeping you current

Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth
Clinical and Experimental Metastasis, 03/19/10

Melanoma MicroRNA Signature Predicts Post-Recurrence Survival
Clinical Cancer Research, 03/16/10

Increased melanoma risk in Parkinson disease: A prospective clinicopathological study
Archives of Neurology, 03/12/10


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address